Literature DB >> 25557080

Organoid models of human and mouse ductal pancreatic cancer.

Sylvia F Boj1, Chang-Il Hwang2, Lindsey A Baker2, Iok In Christine Chio2, Dannielle D Engle2, Vincenzo Corbo2, Myrthe Jager3, Mariano Ponz-Sarvise2, Hervé Tiriac2, Mona S Spector2, Ana Gracanin1, Tobiloba Oni4, Kenneth H Yu5, Ruben van Boxtel3, Meritxell Huch3, Keith D Rivera6, John P Wilson6, Michael E Feigin2, Daniel Öhlund2, Abram Handly-Santana7, Christine M Ardito-Abraham2, Michael Ludwig2, Ela Elyada2, Brinda Alagesan8, Giulia Biffi2, Georgi N Yordanov7, Bethany Delcuze2, Brianna Creighton2, Kevin Wright2, Youngkyu Park2, Folkert H M Morsink9, I Quintus Molenaar10, Inne H Borel Rinkes10, Edwin Cuppen3, Yuan Hao6, Ying Jin6, Isaac J Nijman3, Christine Iacobuzio-Donahue11, Steven D Leach11, Darryl J Pappin6, Molly Hammell6, David S Klimstra12, Olca Basturk12, Ralph H Hruban13, George Johan Offerhaus9, Robert G J Vries1, Hans Clevers14, David A Tuveson15.   

Abstract

Pancreatic cancer is one of the most lethal malignancies due to its late diagnosis and limited response to treatment. Tractable methods to identify and interrogate pathways involved in pancreatic tumorigenesis are urgently needed. We established organoid models from normal and neoplastic murine and human pancreas tissues. Pancreatic organoids can be rapidly generated from resected tumors and biopsies, survive cryopreservation, and exhibit ductal- and disease-stage-specific characteristics. Orthotopically transplanted neoplastic organoids recapitulate the full spectrum of tumor development by forming early-grade neoplasms that progress to locally invasive and metastatic carcinomas. Due to their ability to be genetically manipulated, organoids are a platform to probe genetic cooperation. Comprehensive transcriptional and proteomic analyses of murine pancreatic organoids revealed genes and pathways altered during disease progression. The confirmation of many of these protein changes in human tissues demonstrates that organoids are a facile model system to discover characteristics of this deadly malignancy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25557080      PMCID: PMC4334572          DOI: 10.1016/j.cell.2014.12.021

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  59 in total

1.  Protein labeling by iTRAQ: a new tool for quantitative mass spectrometry in proteome research.

Authors:  Sebastian Wiese; Kai A Reidegeld; Helmut E Meyer; Bettina Warscheid
Journal:  Proteomics       Date:  2007-02       Impact factor: 3.984

2.  Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro.

Authors:  Nick Barker; Meritxell Huch; Pekka Kujala; Marc van de Wetering; Hugo J Snippert; Johan H van Es; Toshiro Sato; Daniel E Stange; Harry Begthel; Maaike van den Born; Esther Danenberg; Stieneke van den Brink; Jeroen Korving; Arie Abo; Peter J Peters; Nick Wright; Richard Poulsom; Hans Clevers
Journal:  Cell Stem Cell       Date:  2010-01-08       Impact factor: 24.633

3.  An in vivo platform for translational drug development in pancreatic cancer.

Authors:  Belen Rubio-Viqueira; Antonio Jimeno; George Cusatis; Xianfeng Zhang; Christine Iacobuzio-Donahue; Collins Karikari; Chanjusn Shi; Kathleen Danenberg; Peter V Danenberg; Hidekazu Kuramochi; Koji Tanaka; Sharat Singh; Hossein Salimi-Moosavi; Nadia Bouraoud; Maria L Amador; Soner Altiok; Piotr Kulesza; Charles Yeo; Wells Messersmith; James Eshleman; Ralph H Hruban; Anirban Maitra; Manuel Hidalgo
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

Review 4.  Gene regulation by nucleoporins and links to cancer.

Authors:  Alwin Köhler; Ed Hurt
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

5.  Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.

Authors:  Maria C Villarroel; N V Rajeshkumar; Ignacio Garrido-Laguna; Ana De Jesus-Acosta; Siân Jones; Anirban Maitra; Ralph H Hruban; James R Eshleman; Alison Klein; Daniel Laheru; Ross Donehower; Manuel Hidalgo
Journal:  Mol Cancer Ther       Date:  2010-12-06       Impact factor: 6.261

Review 6.  Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents.

Authors:  Sreenath V Sharma; Daniel A Haber; Jeff Settleman
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

7.  Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas.

Authors:  Meritxell Rovira; Sherri-Gae Scott; Andrew S Liss; Jan Jensen; Sarah P Thayer; Steven D Leach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

8.  Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.

Authors:  John P Morris; David A Cano; Shigeki Sekine; Sam C Wang; Matthias Hebrok
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

9.  Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model.

Authors:  Kevin C Ray; Kayla M Bell; Jingbo Yan; Guoqiang Gu; Christine H Chung; M Kay Washington; Anna L Means
Journal:  PLoS One       Date:  2011-02-02       Impact factor: 3.240

10.  Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.

Authors:  Sharon Y Gidekel Friedlander; Gerald C Chu; Eric L Snyder; Nomeda Girnius; Gregory Dibelius; Denise Crowley; Eliza Vasile; Ronald A DePinho; Tyler Jacks
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

View more
  675 in total

1.  CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade.

Authors:  Yuji Sato; Jennifer K Bolzenius; Abdallah M Eteleeb; Xinming Su; Christopher A Maher; Jennifer K Sehn; Vivek K Arora
Journal:  JCI Insight       Date:  2018-12-06

2.  The boom in mini stomachs, brains, breasts, kidneys and more.

Authors:  Cassandra Willyard
Journal:  Nature       Date:  2015-07-30       Impact factor: 49.962

Review 3.  A Biologist's Field Guide to Multiplexed Quantitative Proteomics.

Authors:  Corey E Bakalarski; Donald S Kirkpatrick
Journal:  Mol Cell Proteomics       Date:  2016-02-12       Impact factor: 5.911

4.  Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.

Authors:  Luisa F Escobar-Hoyos; Alex Penson; Ram Kannan; Hana Cho; Chun-Hao Pan; Rohit K Singh; Lisa H Apken; G Aaron Hobbs; Renhe Luo; Nicolas Lecomte; Sruthi Babu; Fong Cheng Pan; Direna Alonso-Curbelo; John P Morris; Gokce Askan; Olivera Grbovic-Huezo; Paul Ogrodowski; Jonathan Bermeo; Joseph Saglimbeni; Cristian D Cruz; Yu-Jui Ho; Sharon A Lawrence; Jerry P Melchor; Grant A Goda; Karen Bai; Alessandro Pastore; Simon J Hogg; Srivatsan Raghavan; Peter Bailey; David K Chang; Andrew Biankin; Kenneth R Shroyer; Brian M Wolpin; Andrew J Aguirre; Andrea Ventura; Barry Taylor; Channing J Der; Daniel Dominguez; Daniel Kümmel; Andrea Oeckinghaus; Scott W Lowe; Robert K Bradley; Omar Abdel-Wahab; Steven D Leach
Journal:  Cancer Cell       Date:  2020-06-18       Impact factor: 31.743

5.  Genetic Engineering of Primary Mouse Intestinal Organoids Using Magnetic Nanoparticle Transduction Viral Vectors for Frozen Sectioning.

Authors:  Lingling Xian; Lionel Chia; Dan Georgess; Li Luo; Shuai Shuai; Andrew J Ewald; Linda M S Resar
Journal:  J Vis Exp       Date:  2019-05-10       Impact factor: 1.355

Review 6.  Organ-on-a-Chip for Cancer and Immune Organs Modeling.

Authors:  Wujin Sun; Zhimin Luo; Junmin Lee; Han-Jun Kim; KangJu Lee; Peyton Tebon; Yudi Feng; Mehmet R Dokmeci; Shiladitya Sengupta; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2019-01-03       Impact factor: 9.933

7.  Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer Organoids.

Authors:  Tatiana A Karakasheva; Takashi Kijima; Masataka Shimonosono; Hisatsugu Maekawa; Varun Sahu; Joel T Gabre; Ricardo Cruz-Acuña; Veronique Giroux; Veena Sangwan; Kelly A Whelan; Shoji Natsugoe; Angela J Yoon; Elizabeth Philipone; Andres J Klein-Szanto; Gregory G Ginsberg; Gary W Falk; Julian A Abrams; Jianwen Que; Devraj Basu; Lorenzo Ferri; J Alan Diehl; Adam J Bass; Timothy C Wang; Anil K Rustgi; Hiroshi Nakagawa
Journal:  Curr Protoc Stem Cell Biol       Date:  2020-06

Review 8.  Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine.

Authors:  Erik S Knudsen; Eileen M O'Reilly; Jonathan R Brody; Agnieszka K Witkiewicz
Journal:  Gastroenterology       Date:  2015-09-15       Impact factor: 22.682

Review 9.  Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models.

Authors:  Katya D'Costa; Milena Kosic; Angus Lam; Azeen Moradipour; Yimu Zhao; Milica Radisic
Journal:  Ann Biomed Eng       Date:  2020-04-13       Impact factor: 3.934

10.  KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.

Authors:  Faraz Bishehsari; Lijuan Zhang; Usman Barlass; Nailliw Z Preite; Sanja Turturro; Matthew S Najor; Brandon B Shetuni; Janet P Zayas; Mahboobeh Mahdavinia; Abde M Abukhdeir; Ali Keshavarzian
Journal:  Int J Cancer       Date:  2018-08-09       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.